Deep sequencing of historical samples of patients that have gone on to develop AML has suggested that mutations in TP53, IDH1, and 2 and RNA splicing factors (SRSF2, SF3B1, and U2AF1) are associated with the highest odds of transformation. The gene discussed is IDH1; the disease is acute myeloid leukemia.